High treatment adherence, satisfaction, motivation, and health-related quality of life with fingolimod in patients with relapsing-remitting multiple sclerosis – results from a 24-month, multicenter, open-label Danish study-Reference-Cited by-同舟云学术

High treatment adherence, satisfaction, motivation, and health-related quality of life with fingolimod in patients with relapsing-remitting multiple sclerosis – results from a 24-month, multicenter, open-label Danish study

Published:2018-06 Issue: Volume:Volume 12 Page:1139-1150
ISSN:1177-889X
Container-title:Patient Preference and Adherence
language:en
Short-container-title:PPA

Author:

Schreiber Karen Ingrid^ORCID,Kant Matthias,Pfleger Claudia,Jensen Henrik,Oesterberg Ole^ORCID,Hald Anne Rieper,Nielsen Frederik^ORCID,Rubak Sune^ORCID

Publisher

Informa UK Limited

Subject

Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Social Sciences (miscellaneous),Medicine (miscellaneous)

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Personalized Intervention to Improve Medication Adherence for Persons with Multiple Sclerosis;Patient Preference and Adherence;2024-06

2. Using an Intervention Mapping Approach to Improve Adherence to Disease-Modifying Treatment in Multiple Sclerosis;International Journal of MS Care;2023-09-01

3. A Prospective, Observational Study Assessing Effectiveness, Safety, and QoL of Greek Patients with Multiple Sclerosis Under Treatment with Fingolimod;Advances in Therapy;2023-03-10

4. Predicting improvement of quality of life and mental health over 18-months in multiple sclerosis patients;Multiple Sclerosis and Related Disorders;2021-08

5. TEMPORARY REMOVAL: Efectividad, persistencia del tratamiento y seguridad a largo plazo de fingolimod en pacientes con esclerosis múltiple en la práctica habitual. Resultados del Registro de 24 meses de pacientes argentinos tratados con fingolimod (REAL);Neurología Argentina;2021-01